I

Itama Ranoraya PT
IDX:IRRA

Watchlist Manager
Itama Ranoraya PT
IDX:IRRA
Watchlist
Price: 418 IDR -1.88% Market Closed
Market Cap: Rp668.8B

Operating Margin

9.7%
Current
Improving
by 2.2%
vs 3-y average of 7.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
9.7%
=
Operating Income
Rp135.8B
/
Revenue
Rp1.4T

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
9.7%
=
Operating Income
Rp135.8B
/
Revenue
Rp1.4T

Peer Comparison

Country Company Market Cap Operating
Margin
ID
Itama Ranoraya PT
IDX:IRRA
642.3B IDR
Loading...
US
Mckesson Corp
NYSE:MCK
102.5B USD
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
69B USD
Loading...
US
Cencora Inc
NYSE:COR
68.5B USD
Loading...
US
Cardinal Health Inc
NYSE:CAH
50.8B USD
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
35.5B AUD
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64.6B CNY
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
64.2B CNY
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
9.1B USD
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
65.8B HKD
Loading...

Market Distribution

In line with most companies in Indonesia
Percentile
60th
Based on 1 283 companies
60th percentile
9.7%
Low
-111 644.7% — 0%
Typical Range
0% — 12.9%
High
12.9% — 524 864.9%
Distribution Statistics
Indonesia
Min -111 644.7%
30th Percentile 0%
Median 6.1%
70th Percentile 12.9%
Max 524 864.9%

Itama Ranoraya PT
Glance View

Market Cap
668.8B IDR
Industry
Health Care

PT Itama Ranoraya Tbk operates as a medical devices distributor. The company is headquartered in Jakarta Timur, Dki Jakarta and currently employs 169 full-time employees. The company went IPO on 2019-10-15. The firm operates in the field of wholesale trading of laboratory equipment, pharmaceutical equipment, and medical devices for humans. The firm carries out its operations through four products, namely the non-electromedical sterile medical devices, in-vitro diagnostic, electromedical sterile medical devices, and other products. Its business segment focuses on in-vitro diagnostic (IVD), medical imaging, surgical instrument and disposable, critical care, blood banking and transfusion, cardiovascular, brain management, cancer, urology, and maternal and neonatal care. Its products include Oneject, Abbott, Terumo, Becton Dickinson (BD), HMD, Vestfrost, Balmed, iGene, AVIMAC, and HemoCue.

IRRA Intrinsic Value
1 109.71 IDR
Undervaluation 62%
Intrinsic Value
Price
I
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
9.7%
=
Operating Income
Rp135.8B
/
Revenue
Rp1.4T
What is Itama Ranoraya PT's current Operating Margin?

The current Operating Margin for Itama Ranoraya PT is 9.7%, which is above its 3-year median of 7.4%.

How has Operating Margin changed over time?

Over the last 3 years, Itama Ranoraya PT’s Operating Margin has decreased from 10.9% to 9.7%. During this period, it reached a low of 3% on Jun 30, 2024 and a high of 10.9% on Aug 30, 2022.

Back to Top